1. Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta® in healthy subjects: A randomized, double‐blind trial. Issue 2 (25th April 2020) Authors: Wynne, Chris; Schwabe, Christian; Vincent, Emmanuelle; Schueler, Armin; Ryding, Janka; Ullmann, Martin; Ghori, Vishal; Kanceva, Radmila; Stahl, Michael Journal: Pharmacology research & perspectives Issue: Volume 8:Issue 2(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Demonstrating biosimilar and originator antidrug antibody binding comparability in antidrug antibody assays: a practical approach. (September 2017) Authors: Ryding, Janka; Stahl, Michael; Ullmann, Martin Journal: Bioanalysis Issue: Volume 9:Number 18(2017) Page Start: 1395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0088 SAFETY, IMMUNOGENICITY AND EFFICACY OF THE PROPOSED BIOSIMILAR MSB11022 (MODIFIED FORMULATION) COMPARED WITH ADALIMUMAB REFERENCE PRODUCT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS: AURIEL-RA, A RANDOMISED, DOUBLE-BLIND, PHASE III STUDY. (June 2019) Authors: Edwards, Christopher; Chyrok, Veronica; Monnet, Joëlle; Ullmann, Martin; Vlachos, Pantelis Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 707 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacokinetics and pharmacodynamics of a proposed tocilizumab biosimilar MSB11456 versus both the US-licensed and EU-approved products: a randomized, double-blind trial. (4th May 2022) Authors: Schwabe, Christian; Illes, Andras; Ullmann, Martin; Ghori, Vishal; Vincent, Emmanuelle; Petit-Frere, Corinne; Monnet, Joelle; Racault, Anne Sophie; Wynne, Chris Journal: Expert review of clinical immunology Issue: Volume 18:Number 5(2022) Page Start: 533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 – LBA, biomarkers and immunogenicity). (November 2016) Authors: Richards, Susan; Amaravadi, Lakshmi; Pillutla, Renuka; Birnboeck, Herbert; Torri, Albert; Cowan, Kyra J.; Papadimitriou, Apollon; Garofolo, Fabio; Satterwhite, Christina; Piccoli, Steven; Wu, Bonnie; Krinos-Fiorotti, Corinna; Allinson, John; Berisha, Flora; Cocea, Laurent; Croft, Stephanie; Frase... Journal: Bioanalysis Issue: Volume 8:Number 23(2016) Page Start: 2475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 – LBA/cell-based assays: immunogenicity, biomarkers and PK assays). (29th November 2018) Authors: Stevenson, Lauren; Richards, Susan; Pillutla, Renuka; Torri, Albert; Kamerud, John; Mehta, Devangi; Keller, Stephen; Purushothama, Shobha; Gorovits, Boris; Litwin, Virginia; Stebbins, Christopher; Marini, Joseph; Beaver, Chris; Sperinde, Gizette; Siguenza, Patricia; Staack, Roland F; Qiu, Yongcha... Journal: Bioanalysis Issue: Volume 10:Number 24(2018) Page Start: 1973 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira® in healthy subjects. (28th July 2016) Authors: Hyland, Elizabeth; Mant, Tim; Vlachos, Pantelis; Attkins, Neil; Ullmann, Martin; Roy, Sanjeev; Wagner, Volker Journal: British journal of clinical pharmacology Issue: Volume 82:Number 4(2016:Oct.) Page Start: 983 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Application of proper orthogonal decomposition methods in reactive pore diffusion simulations. (17th August 2014) Authors: Ullmann, Martin; Prüfert, Uwe; Seidel, Jens; Ernst, Oliver G.; Hasse, Christian Journal: Canadian journal of chemical engineering Issue: Volume 92:Number 9(2014) Page Start: 1552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacokinetics of a proposed tocilizumab biosimilar (MSB11456) versus US-licensed tocilizumab: results of a randomized, double-blind, single-intravenous dose study in healthy adults. (3rd April 2023) Authors: Tomaszewska-Kiecana, Monika; Ullmann, Martin; Petit-Frere, Corinne; Monnet, Joëlle; Dagres, Christos; Illes, Andras Journal: Expert review of clinical immunology Issue: Volume 19:Number 4(2023) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults. (3rd April 2023) Authors: Tomaszewska-Kiecana, Monika; Dryja, Anna; Ullmann, Martin; Petit-Frere, Corinne; Illes, Andras; Dagres, Christos; Monnet, Joëlle Journal: Expert review of clinical immunology Issue: Volume 19:Number 4(2023) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗